Integramed America, Inc. (INMD) Tops Q4 EPS by 3c, Sales Top Consensus
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Price: $13.35 +1.06%
EPS Growth %: -27.7%
Financial Fact:
Revenues, net: 51.26M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -27.7%
Financial Fact:
Revenues, net: 51.26M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $70.88 million versus the consensus estimate of $69.58 million.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Cal-Maine Foods adds two independent directors, expanding board to ten
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
